191 related articles for article (PubMed ID: 31988093)
21. MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells.
Yalcin A; Kreutz C; Pfeifer D; Abdelkarim M; Klaus G; Timmer J; Lübbert M; Hackanson B
Leuk Res; 2013 Jan; 37(1):102-11. PubMed ID: 23062266
[TBL] [Abstract][Full Text] [Related]
22. High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias.
Magi A; Mattei G; Mingrino A; Caprioli C; Ronchini C; Frigè G; Semeraro R; Bolognini D; Rambaldi A; Candoni A; Colombo E; Mazzarella L; Pelicci PG
Commun Biol; 2023 Apr; 6(1):382. PubMed ID: 37031307
[TBL] [Abstract][Full Text] [Related]
23. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
24. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
25. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
26. Nucleosome repositioning during differentiation of a human myeloid leukemia cell line.
Teif VB; Mallm JP; Sharma T; Mark Welch DB; Rippe K; Eils R; Langowski J; Olins AL; Olins DE
Nucleus; 2017 Mar; 8(2):188-204. PubMed ID: 28406749
[TBL] [Abstract][Full Text] [Related]
27. Whole-genome fingerprint of the DNA methylome during human B cell differentiation.
Kulis M; Merkel A; Heath S; Queirós AC; Schuyler RP; Castellano G; Beekman R; Raineri E; Esteve A; Clot G; Verdaguer-Dot N; Duran-Ferrer M; Russiñol N; Vilarrasa-Blasi R; Ecker S; Pancaldi V; Rico D; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Pascual M; Agirre X; Prosper F; Alignani D; Paiva B; Caron G; Fest T; Muench MO; Fomin ME; Lee ST; Wiemels JL; Valencia A; Gut M; Flicek P; Stunnenberg HG; Siebert R; Küppers R; Gut IG; Campo E; Martín-Subero JI
Nat Genet; 2015 Jul; 47(7):746-56. PubMed ID: 26053498
[TBL] [Abstract][Full Text] [Related]
28. The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated.
Santana-Lemos BA; de Lima Lange AP; de Lira Benício MT; José TD; Lucena-Araújo AR; Krause A; Thomé CH; Rego EM
Haematologica; 2011 Apr; 96(4):617-20. PubMed ID: 21134977
[TBL] [Abstract][Full Text] [Related]
29. Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia.
Adelman ER; Huang HT; Roisman A; Olsson A; Colaprico A; Qin T; Lindsley RC; Bejar R; Salomonis N; Grimes HL; Figueroa ME
Cancer Discov; 2019 Aug; 9(8):1080-1101. PubMed ID: 31085557
[TBL] [Abstract][Full Text] [Related]
30. Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms.
Silva G; Cardoso BA; Belo H; Almeida AM
PLoS One; 2013; 8(1):e53766. PubMed ID: 23320102
[TBL] [Abstract][Full Text] [Related]
31. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
32. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Herwig S; Su Q; Zhang W; Ma Y; Tempst P
Blood; 1996 Jan; 87(1):350-64. PubMed ID: 8547662
[TBL] [Abstract][Full Text] [Related]
33. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R
Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908
[TBL] [Abstract][Full Text] [Related]
34. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of microRNA-34b expression in pediatric acute leukemia.
Cao L; Wang N; Pan J; Hu S; Zhao W; He H; Wang Y; Gu G; Chai Y
Mol Med Rep; 2016 Mar; 13(3):2777-84. PubMed ID: 26861642
[TBL] [Abstract][Full Text] [Related]
36. CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors.
Negrotto S; Ng KP; Jankowska AM; Bodo J; Gopalan B; Guinta K; Mulloy JC; Hsi E; Maciejewski J; Saunthararajah Y
Leukemia; 2012 Feb; 26(2):244-54. PubMed ID: 21836612
[TBL] [Abstract][Full Text] [Related]
37. Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics.
Farlik M; Sheffield NC; Nuzzo A; Datlinger P; Schönegger A; Klughammer J; Bock C
Cell Rep; 2015 Mar; 10(8):1386-97. PubMed ID: 25732828
[TBL] [Abstract][Full Text] [Related]
38. Low-Input Whole-Genome Bisulfite Sequencing.
Krepelova A; Neri F
Methods Mol Biol; 2021; 2351():353-368. PubMed ID: 34382200
[TBL] [Abstract][Full Text] [Related]
39. Epigenome-wide analysis reveals specific DNA hypermethylation of T cells during human hematopoietic differentiation.
Tejedor JR; Bueno C; Cobo I; Bayón GF; Prieto C; Mangas C; Pérez RF; Santamarina P; Urdinguio RG; Menéndez P; Fraga MF; Fernández AF
Epigenomics; 2018 Jul; 10(7):903-923. PubMed ID: 29620943
[TBL] [Abstract][Full Text] [Related]
40. Distinct epigenomic features in end-stage failing human hearts.
Movassagh M; Choy MK; Knowles DA; Cordeddu L; Haider S; Down T; Siggens L; Vujic A; Simeoni I; Penkett C; Goddard M; Lio P; Bennett MR; Foo RS
Circulation; 2011 Nov; 124(22):2411-22. PubMed ID: 22025602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
